Prozone effect of serum IgE levels in a case of plasma cell leukemia
Related Experiment Video
Updated: Feb 17, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Giampaolo Talamo1, William Castellani, Nathan G Dolloff
1Penn State Hershey Cancer Institute, 500 University Drive, Hershey, PA 17033, USA. gtalamo@hmc.psu.edu
Insights
This case study highlights a rare IgE-kappa multiple myeloma with secondary plasma cell leukemia. The prozone effect complicated monitoring, emphasizing the need for careful interpretation of tumor markers.
Area of Science:
- Hematology
- Clinical Chemistry
- Immunology
Background:
- Multiple myeloma (MM) is a plasma cell malignancy.
- Secondary plasma cell leukemia (PCL) is a rare, aggressive complication of MM.
- IgE-producing plasma cell neoplasms are exceptionally rare.
Observation:
- A unique case of MM with secondary PCL secreting IgE-kappa immunoglobulin is presented.
- Standard tumor markers like serum free light chains and Bence-Jones proteinuria were uninformative.
- Quantitative serum IgE levels yielded inaccurate results due to the prozone effect.
Findings:
- The prozone effect, caused by antigen excess, interfered with IgE detection methods.
- The M component measured by serum protein electrophoresis (SPEP) was the sole reliable marker for therapeutic response.
- Accurate interpretation of tumor markers is crucial for managing rare IgE-producing PCL.
Implications:
- Clinicians must be aware of the prozone effect and its potential to mask disease progression.
- Alternative or modified laboratory methods may be needed for accurate monitoring of IgE-secreting neoplasms.
- This case underscores the heterogeneity of plasma cell disorders and challenges in their laboratory assessment.
Abstract:
We describe a case of multiple myeloma (MM) and secondary plasma cell leukemia (PCL) secreting IgE-kappa immunoglobulin. To our knowledge, only 2 cases of IgE-producing secondary PCL have been reported in the medical literature. In our patient, the only tumor marker available for monitoring the therapeutic response to chemotherapy and allogeneic stem cell transplantation was the quantitative M component at serum protein electrophoresis (SPEP), because serum free light chains were in the normal range, Bence-Jones proteinuria was absent, and quantitative serum IgE levels provided inaccurate and erratic results, due to the prozone effect. This is a laboratory phenomenon that occurs when antigen excess interferes with antibody-based methods requiring immune complex formation for detection. It is important to recognize the presence of a prozone effect, because it can produce falsely normal results, and therefore it could lead clinicians to incorrect assessment of the response to therapy.
More Related Videos
08:26The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity
Published on: December 14, 2016
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014